Active	Status	Sponsor type	Region	Phase	Filter
1 Active 0 Inactive 1 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Kang, Jin-Hyong
NCT04901806 / 2021-001029-32: Study of PBI-200 in Subjects With NTRK-Fusion-Positive Solid Tumors	Terminated	1	29	Europe, US, RoW	PBI-200	Pyramid Biosciences, Pyramid Biosciences, Inc., Pyramid Biosciences	Solid Tumor, Adult, Brain Tumor, Primary, Desmoplastic Small Round Cell Tumor	07/23	07/23